Generic competition · all medicines · read 12 November 2026
Is there a generic of Valsartan, and who makes it?
Valsartan appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 18 generic makers listed as marketed across them. Where both are dated, the first generic approval came between 3.9 and 12.9 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Method designed and maintained by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). Data compiled automatically from the Orange Book data files, downloaded 12 November 2026. How these pages are made
- Valsartan appears in 3 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 18 generic makers listed as marketed across them.
- Where both are dated, the first generic approval came between 3.9 and 12.9 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Tablet, Oral
Four or more generic makers listed
Brand listed as marketed: Diovan. 16 generic makers with 64 generic products listed as marketed; the first generic approval is dated 26 June 2014.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Ohm Laboratories Inc | 26 June 2014 | 4 |
| Alembic Pharmaceuticals Ltd | 5 January 2015 | 4 |
| Aurobindo Pharma Ltd | 5 January 2015 | 4 |
| Hetero Labs Ltd Unit V | 5 January 2015 | 4 |
| Jubilant Generics Ltd | 5 January 2015 | 4 |
| Mylan Pharmaceuticals Inc | 5 January 2015 | 4 |
| Prinston Pharmaceutical Inc | 9 June 2015 | 4 |
| Amneal Pharmaceuticals Of New York Llc | 11 January 2016 | 4 |
| Macleods Pharmaceuticals Ltd | 16 September 2016 | 4 |
| Adaptis Pharma Private Ltd | 9 April 2018 | 4 |
| Alkem Laboratories Ltd | 12 March 2019 | 4 |
| Dr Reddys Laboratories Ltd | 5 October 2021 | 4 |
4 more makers are listed in the data.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution, Oral
One to three generic makers listed
Brand listed as marketed: Prexxartan. 2 generic makers with 2 generic products listed as marketed; the first generic approval is dated 2 November 2021.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Novitium Pharma Llc | 2 November 2021 | 1 |
| Rubicon Research Ltd | 5 June 2025 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Capsule, Oral
Nothing listed as marketed
Every brand product here is listed as discontinued. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
What do pharmacies pay for Valsartan?
The CMS NADAC survey tracks what pharmacies pay to acquire Valsartan: 4 products with year-end prices from 2014 to 2026. See the acquisition cost history on RxGrab. It is a pharmacy cost, not a retail price, and this page does not say how it relates to the number of makers listed above.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.